Company / Book Value per Share
Veracyte, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$16.839
FY2025
5-year range
$14.51 / $18.84
FY2021-FY2025
Trend
+4.9%
vs FY2024
Sector context
#73 of 163
Health Care
What the data says
At $16.839, Veracyte, Inc.'s book value per share ranks #73 of 163 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from $1.103 in FY2017 to $18.84 in FY2021.
Based on SEC 10-K filings.
$16.839 in FY2025 with a 5-year CAGR of +14.7%.
Improved from $14.51 to $16.839 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +3.7%
- 5-Year CAGR
- +14.7%
- 10-Year CAGR
- -
Sector benchmark
#73 of 163 in Health CareTop 45% of 163This company $16.839 Sector average $47.405
▼
-64.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.7%, indicating consistent growth.
- In FY2025, book value per share increased 4.9% year-over-year.
- Ranks #73 out of 163 companies in the Health Care sector.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.839 | +4.9% |
| FY2024 | $16.051 | +10.6% |
| FY2023 | $14.51 | -4.0% |
| FY2022 | $15.117 | -19.8% |
| FY2021 | $18.84 | +122.0% |
| FY2020 | $8.488 | +44.9% |
| FY2019 | $5.86 | +148.1% |
| FY2018 | $2.362 | +114.3% |
| FY2017 | $1.103 | -48.8% |
| FY2016 | $2.152 | -5.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026